Please use this identifier to cite or link to this item:
https://doi.org/10.3390/genes9070351
DC Field | Value | |
---|---|---|
dc.title | Targeted approaches for in situ gut microbiome manipulation | |
dc.contributor.author | Lee, H.L | |
dc.contributor.author | Shen, H | |
dc.contributor.author | Hwang, I.Y | |
dc.contributor.author | Ling, H | |
dc.contributor.author | Yew, W.S | |
dc.contributor.author | Lee, Y.S | |
dc.contributor.author | Chang, M.W | |
dc.date.accessioned | 2020-09-09T03:09:52Z | |
dc.date.available | 2020-09-09T03:09:52Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Lee, H.L, Shen, H, Hwang, I.Y, Ling, H, Yew, W.S, Lee, Y.S, Chang, M.W (2018). Targeted approaches for in situ gut microbiome manipulation. Genes 9 (7) : 351. ScholarBank@NUS Repository. https://doi.org/10.3390/genes9070351 | |
dc.identifier.issn | 20734425 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/175053 | |
dc.description.abstract | Microbial communities and their collective genomes form the gut microbiome, of which bacteria are the major contributor. Through their secreted metabolites, bacteria interact with the host, influencing human health and physiology. Perturbation of the microbiota and metabolome has been associated with various diseases and metabolic conditions. As knowledge on fundamental host-microbiome interactions and genetic engineering tools becomes readily available, targeted manipulation of the gut microbiome for therapeutic applications gains favourable attention. Manipulation of the gut microbiome can be achieved by altering the microbiota population and composition, or by modifying the functional metabolic activity of the microbiome to promote health and restore the microbiome balance. In this article, we review current works that demonstrate various strategies employed to manipulate the gut microbiome in situ to various degrees of precision. © 2018 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.source | Unpaywall 20200831 | |
dc.subject | prebiotic agent | |
dc.subject | probiotic agent | |
dc.subject | bacterial colonization | |
dc.subject | bacterial strain | |
dc.subject | Bacteroides thetaiotaomicron | |
dc.subject | Bifidobacterium | |
dc.subject | Bifidobacterium adolescentis | |
dc.subject | Caenorhabditis elegans | |
dc.subject | Clostridium | |
dc.subject | CRISPR-CAS9 system | |
dc.subject | Crohn disease | |
dc.subject | Enterococcus faecalis | |
dc.subject | Escherichia coli | |
dc.subject | Eubacterium | |
dc.subject | Faecalibacterium prausnitzii | |
dc.subject | genetic engineering | |
dc.subject | genetic manipulation | |
dc.subject | in vivo study | |
dc.subject | intestine flora | |
dc.subject | Lactobacillus rhamnosus | |
dc.subject | Lactobacillus sakei | |
dc.subject | Lactococcus lactis | |
dc.subject | Listeria monocytogenes | |
dc.subject | measurement precision | |
dc.subject | nonhuman | |
dc.subject | Peptoclostridium difficile | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Review | |
dc.subject | Roseburia | |
dc.subject | ulcerative colitis | |
dc.subject | Vibrio cholerae | |
dc.type | Review | |
dc.contributor.department | DEPT OF BIOCHEMISTRY | |
dc.contributor.department | DEPT OF PAEDIATRICS | |
dc.description.doi | 10.3390/genes9070351 | |
dc.description.sourcetitle | Genes | |
dc.description.volume | 9 | |
dc.description.issue | 7 | |
dc.description.page | 351 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3390_genes9070351.pdf | 1 MB | Adobe PDF | OPEN | None | View/Download |
SCOPUSTM
Citations
24
checked on May 26, 2023
Page view(s)
216
checked on May 25, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.